Most download articles

  • HOME
  • BROWSE ARTICLES
  • Most download articles

From articles published in J Urol Oncol during the past two years (2022~ ).

Reivew Article
532
Complex Epidemiology of Prostate Cancer in Asian Countries   (123 times)
Kagenori Ito, Takahiro Kimura
Journal of Urologic Oncology. 2023;21(1):5-13.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Review Article
Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?   (140 times)
Jae Duck Choi, Jeong Man Cho, Tag Keun Yoo
Korean J Urol Oncol. 2022;20(3):139-150.   Published online August 25, 2022
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Reivew Article
533
Current Update on Prostate Cancer Immunotherapy   (98 times)
Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim
Journal of Urologic Oncology. 2023;21(1):14-22.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Invited Review
553
Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma   (29 times)
Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, Mehmet A. Bilen, Kenneth Ogan, Viraj A. Master
Journal of Urologic Oncology. 2023;21(3):183-199.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Invited Review
555
The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects   (28 times)
Hyerim Ha, Joo Han Lim
Journal of Urologic Oncology. 2023;21(3):208-216.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Review Article
523
An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer   (137 times)
Jeong Hee Hong
Korean J Urol Oncol. 2022;20(4):207-222.   Published online November 30, 2022
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
Invited Review
557
Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023   (25 times)
Jiwoong Yu, Hyun Hwan Sung
Journal of Urologic Oncology. 2023;21(3):228-240.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Topic Article
554
Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis   (23 times)
Jin Noh, Sang Hun Song, Gyoohwan Jung, Sangchul Lee, Sung Kyu Hong, Seok Soo Byun, Jung Kwon Kim
Journal of Urologic Oncology. 2023;21(3):200-207.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Review Article
The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer   (116 times)
Jae Young Joung, Sung Han Kim
Korean J Urol Oncol. 2022;20(1):1-11.   Published online February 24, 2022
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
Invited Review
544
The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance   (42 times)
Chang Wook Jeong
Journal of Urologic Oncology. 2023;21(2):97-105.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
Invited Review
545
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials   (30 times)
Sang Hun Song, Jong Jin Oh
Journal of Urologic Oncology. 2023;21(2):154-164.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Review Article
519
Artificial Intelligence on Urology Lab   (95 times)
Jae Baek Ha, Jaewoon Jeong, Jeongyoon Suh, Sungyun Park, Ruei Ting Wang, Taewoo Kim, Ji Eun Koh, Jong Hyun Tae, In Ho Chang, Se Young Choi
Korean J Urol Oncol. 2022;20(3):163-176.   Published online August 25, 2022
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Reivew Article
534
The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies   (58 times)
Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, Takayuki Goto, Takashi Kobayashi
Journal of Urologic Oncology. 2023;21(1):23-31.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Original Article
549
Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis   (40 times)
Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, Jongchan Kim, Won Sik Jang, Jee Soo Park, Won Sik Ham
Journal of Urologic Oncology. 2023;21(2):165-173.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Original Article
536
Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database   (46 times)
Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, Woo Suk Choi, Yun-Sok Ha, Jeong Hyun Kim, Cheol Kwak
Journal of Urologic Oncology. 2023;21(1):45-52.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
Original Article
558
Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy   (15 times)
Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, Won Hoon Song, Seung Soo Lee, Sung Woo Park, Jong Kil Nam
Journal of Urologic Oncology. 2023;21(3):249-256.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Clinical Predictors of ARTA Response in Metastatic Prostate Cancer
Original Article
561
Negative Delta-Prostate-Specific Antigen Time Ratio as Potential New Marker of Progression-Free Survival in Castration-Resistant Prostate Cancer Patients Treated With First-Line Enzalutamide or Docetaxel   (15 times)
Tae Hwan Kim, Seol Ho Choo, Kang Hee Shim, Sun Il Kim
Journal of Urologic Oncology. 2023;21(3):271-276.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Original Article
Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey   (38 times)
Joongwon Choi, Cheryn Song, Jungyo Suh, Minyong Kang, Chang Il Choi, Hyeong Dong Yuk, Chan Ho Lee, Jung Kwon Kim, Jung Ki Jo, Won Sik Ham, Eu Chang Hwang, Chang Wook Jeong, Young Hwii Ko, Jae Young Park, Seong Il Seo, Byung Kwan Park, Jinsoo Chung, Cheol Kwak, Sung-Hoo Hong
Journal of Urologic Oncology. 2023;21(1):59-69.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Invited Review
556
Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type   (13 times)
Chan Woo Wee, Jaeho Cho
Journal of Urologic Oncology. 2023;21(3):217-227.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Clinical Predictors of ARTA Response in Metastatic Prostate Cancer
Topic Article
559
Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer   (13 times)
Jaeyoung Cho, Jungyo Suh, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Hanjong Ahn, Bumjin Lim
Journal of Urologic Oncology. 2023;21(3):257-263.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043



Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.

Developed in M2PI